Literature DB >> 20798780

Increased Human Wildtype Tau Attenuates Axonal Transport Deficits Caused by Loss of APP in Mouse Models.

Karen D B Smith1, Erica Peethumnongsin, Han Lin, Hui Zheng, Robia G Pautler.   

Abstract

Amyloid precursor protein (APP) is implicated in axonal elongation, synaptic plasticity, and axonal transport. However, the role of APP on axonal transport in conjunction with the microtubule associated protein tau continues to be debated. Here we measured in vivo axonal transport in APP knockout mice with Manganese Enhanced MRI (MEMRI) to determine whether APP is necessary for maintaining normal axonal transport. We also tested how overexpression and mutations of tau affect axonal transport in the presence or absence of APP. In vivo axonal transport reduced significantly in the absence of functional APP. Overexpression of human wildtype tau maintained normal axonal transport and resulted in a transient compensation of axonal transport deficits in the absence of APP. Mutant R406Wtau in combination with the absence of APP compounded axonal transport deficits and these deficits persisted with age. These results indicate that APP is necessary for axonal transport, and overexpression of human wildtype tau can compensate for the absence of APP at an early age.

Entities:  

Year:  2010        PMID: 20798780      PMCID: PMC2927830          DOI: 10.4137/mri.s5237

Source DB:  PubMed          Journal:  Magn Reson Insights        ISSN: 1178-623X


  33 in total

1.  Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP.

Authors:  A Kamal; A Almenar-Queralt; J F LeBlanc; E A Roberts; L S Goldstein
Journal:  Nature       Date:  2001-12-06       Impact factor: 49.962

2.  Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model.

Authors:  Pavan K Krishnamurthy; Gail V W Johnson
Journal:  J Biol Chem       Date:  2003-12-02       Impact factor: 5.157

3.  The FTDP-17-linked mutation R406W abolishes the interaction of phosphorylated tau with microtubules.

Authors:  M Pérez; F Lim; M Arrasate; J Avila
Journal:  J Neurochem       Date:  2000-06       Impact factor: 5.372

4.  Altered microtubule organization in small-calibre axons of mice lacking tau protein.

Authors:  A Harada; K Oguchi; S Okabe; J Kuno; S Terada; T Ohshima; R Sato-Yoshitake; Y Takei; T Noda; N Hirokawa
Journal:  Nature       Date:  1994-06-09       Impact factor: 49.962

5.  Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited.

Authors:  Orly Lazarov; Gerardo A Morfini; Edward B Lee; Mohamed H Farah; Anita Szodorai; Scott R DeBoer; Vassilis E Koliatsos; Stefan Kins; Virginia M-Y Lee; Philip C Wong; Donald L Price; Scott T Brady; Sangram S Sisodia
Journal:  J Neurosci       Date:  2005-03-02       Impact factor: 6.167

6.  Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model.

Authors:  Erik D Roberson; Kimberly Scearce-Levie; Jorge J Palop; Fengrong Yan; Irene H Cheng; Tiffany Wu; Hilary Gerstein; Gui-Qiu Yu; Lennart Mucke
Journal:  Science       Date:  2007-05-04       Impact factor: 47.728

Review 7.  Ageing and neuronal vulnerability.

Authors:  Mark P Mattson; Tim Magnus
Journal:  Nat Rev Neurosci       Date:  2006-04       Impact factor: 34.870

Review 8.  Tau phosphorylation: the therapeutic challenge for neurodegenerative disease.

Authors:  Diane P Hanger; Brian H Anderton; Wendy Noble
Journal:  Trends Mol Med       Date:  2009-02-24       Impact factor: 11.951

9.  Role of neuronal activity and kinesin on tract tracing by manganese-enhanced MRI (MEMRI).

Authors:  Elaine L Bearer; Tomás Luis Falzone; Xiaowei Zhang; Octavian Biris; Arkady Rasin; Russell E Jacobs
Journal:  Neuroimage       Date:  2007-05-13       Impact factor: 6.556

10.  Defective kinesin heavy chain behavior in mouse kinesin light chain mutants.

Authors:  A Rahman; A Kamal; E A Roberts; L S Goldstein
Journal:  J Cell Biol       Date:  1999-09-20       Impact factor: 10.539

View more
  13 in total

1.  Deficits in axonal transport in hippocampal-based circuitry and the visual pathway in APP knock-out animals witnessed by manganese enhanced MRI.

Authors:  Joseph J Gallagher; Xiaowei Zhang; Gregory J Ziomek; Russell E Jacobs; Elaine L Bearer
Journal:  Neuroimage       Date:  2012-02-10       Impact factor: 6.556

2.  Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study.

Authors:  Naruhiko Sahara; Pablo D Perez; Wen-Lang Lin; Dennis W Dickson; Yan Ren; Huadong Zeng; Jada Lewis; Marcelo Febo
Journal:  Neurobiol Aging       Date:  2013-12-19       Impact factor: 4.673

3.  Impact of repeated topical-loaded manganese-enhanced MRI on the mouse visual system.

Authors:  Shu-Wei Sun; Tiffany Thiel; Hsiao-Fang Liang
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-12       Impact factor: 4.799

Review 4.  Axonal transport and neurodegenerative disease: can we see the elephant?

Authors:  Lawrence S B Goldstein
Journal:  Prog Neurobiol       Date:  2012-04-01       Impact factor: 11.685

5.  Non-invasive, in vivo monitoring of neuronal transport impairment in a mouse model of tauopathy using MEMRI.

Authors:  Anne Bertrand; Umer Khan; Dung M Hoang; Dmitry S Novikov; Pavan Krishnamurthy; Hameetha B Rajamohamed Sait; Benjamin W Little; Einar M Sigurdsson; Youssef Z Wadghiri
Journal:  Neuroimage       Date:  2012-08-31       Impact factor: 6.556

6.  Global axonal transport rates are unaltered in htau mice in vivo.

Authors:  Aidong Yuan; Asok Kumar; Takahiro Sasaki; Karen Duff; Ralph A Nixon
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 7.  The airbag problem-a potential culprit for bench-to-bedside translational efforts: relevance for Alzheimer's disease.

Authors:  Dimitrije Krstic; Irene Knuesel
Journal:  Acta Neuropathol Commun       Date:  2013-09-23       Impact factor: 7.801

8.  Pharmocologic treatment with histone deacetylase 6 inhibitor (ACY-738) recovers Alzheimer's disease phenotype in amyloid precursor protein/presenilin 1 (APP/PS1) mice.

Authors:  Tabassum Majid; Deric Griffin; Zachary Criss; Matthew Jarpe; Robia G Pautler
Journal:  Alzheimers Dement (N Y)       Date:  2015-10-11

9.  In vivo axonal transport deficits in a mouse model of fronto-temporal dementia.

Authors:  Tabassum Majid; Yousuf O Ali; Deepa V Venkitaramani; Ming-Kuei Jang; Hui-Chen Lu; Robia G Pautler
Journal:  Neuroimage Clin       Date:  2014-03-31       Impact factor: 4.881

Review 10.  Preclinical Magnetic Resonance Imaging and Spectroscopy Studies of Memory, Aging, and Cognitive Decline.

Authors:  Marcelo Febo; Thomas C Foster
Journal:  Front Aging Neurosci       Date:  2016-06-29       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.